• Vikas Kumar
• March 12, 2023
• HEALTHCARE, NEWS
• Agenus Inc., AstraZeneca, BioNTech SE, BrightPath Biotherapeutics Co. Ltd., F. Hoffmann-La Roche Ltd, Gilead Sciences Inc., Gritstone bio, Innovent, Merck & Co. Inc., Neoantigen Cancer Vaccine, Neoantigen Cancer Vaccine Market, Neoantigen Cancer Vaccine Market analysis, Neoantigen Cancer Vaccine Market forecast, Neoantigen Cancer Vaccine Market growth, Neoantigen Cancer Vaccine Market share, Neoantigen Cancer Vaccine Market size, Neoantigen Cancer Vaccine Market trend, ose-immuno
• 0 Comments

Neoantigens are tumor-specific antigens that are developed from mutated proteins only found in cancer cells. Neoantigen cancer vaccines are novel vaccines that utilize neoantigens to boost the immune system against tumor cells. Owing to this high specificity towards cancer cells, these vaccines have gained considerable momentum in the global market. Pharmaceutical companies is tremendously investing in research activities for the …